Brief: Enorama Pharma Q1 Operating Loss Widens To SEK 5.9 Mln
19/05/2021 08:11
May 19 (Reuters) - Enorama Pharma AB ERMA.ST :
* Q1 NET SALES 1 777 (124) KSEK
* Q1 OPERATING LOSS SEK 5.9 MILLION VERSUS LOSS SEK 5.3
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr57pH5s
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO